Product NDC: | 0955-1025 |
Proprietary Name: | levocetirizine dihydrochloride |
Non Proprietary Name: | levocetirizine dihydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; levocetirizine dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0955-1025 |
Labeler Name: | Winthrop U.S. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022064 |
Marketing Category: | NDA |
Start Marketing Date: | 20070809 |
Package NDC: | 0955-1025-90 |
Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0955-1025-90) |
NDC Code | 0955-1025-90 |
Proprietary Name | levocetirizine dihydrochloride |
Package Description | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0955-1025-90) |
Product NDC | 0955-1025 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levocetirizine dihydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20070809 |
Marketing Category Name | NDA |
Labeler Name | Winthrop U.S. |
Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |